• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于眼药水处方患者不依从性原因的研究。

A study of the causes of non-compliance by patients prescribed eyedrops.

作者信息

Winfield A J, Jessiman D, Williams A, Esakowitz L

机构信息

Pharmacy and Medicine Research Unit, School of Pharmacy, Robert Gordon's Institute of Technology, Aberdeen.

出版信息

Br J Ophthalmol. 1990 Aug;74(8):477-80. doi: 10.1136/bjo.74.8.477.

DOI:10.1136/bjo.74.8.477
PMID:2390523
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1042177/
Abstract

An investigation into the causes of non-compliance by patients using eyedrops has been undertaken by questionnaire, ability tests, and by tests on eyedrop bottles. The results indicate a high prevalence of non-compliance, compounded by an inability adequately to instill a drop into the eye. About half the patients had difficulty aiming the drop, and other problems including squeezing the bottle, blinking, and seeing the tip of the bottle. Ability tests included a measurement of the grip strength of patients to complement measurement of the force required to expel a drop from a bottle. Some patients, particularly those with arthritis, could not generate enough force to squeeze a bottle. These same patients also had difficulty with the other movements required to administer drops. While some attempts have been made to produce devices to assist with eyedrops which can improve the aim of the patient, none give assistance in expelling a drop. An additional problem found was the reluctance of patients to admit to medical staff that they experienced any difficulty with their drops.

摘要

通过问卷调查、能力测试以及对眼药水瓶的测试,对使用眼药水的患者不依从的原因进行了调查。结果表明不依从的发生率很高,而且难以将一滴眼药水充分滴入眼中的情况也加剧了这一问题。大约一半的患者在将眼药水滴入眼睛时难以找准位置,还存在其他问题,包括挤压药瓶、眨眼以及看不到药瓶尖端。能力测试包括测量患者的握力,以补充测量从药瓶中挤出一滴眼药水所需的力。一些患者,尤其是患有关节炎的患者,无法产生足够的力来挤压药瓶。这些患者在进行滴眼药水所需的其他动作时也有困难。虽然已经有人尝试制造辅助滴眼药水的装置,这些装置可以改善患者滴药的准度,但没有一种能帮助挤出眼药水。另外发现的一个问题是,患者不愿意向医护人员承认他们在滴眼药水时遇到任何困难。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b3/1042177/36be0d49d567/brjopthal00582-0032-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b3/1042177/36be0d49d567/brjopthal00582-0032-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b3/1042177/36be0d49d567/brjopthal00582-0032-a.jpg

相似文献

1
A study of the causes of non-compliance by patients prescribed eyedrops.一项关于眼药水处方患者不依从性原因的研究。
Br J Ophthalmol. 1990 Aug;74(8):477-80. doi: 10.1136/bjo.74.8.477.
2
[Improved eyedrop administration and compliance in glaucoma patients. A clinical study].[青光眼患者滴眼液给药方式的改进及依从性:一项临床研究]
Klin Monbl Augenheilkd. 1997 Oct;211(4):257-62. doi: 10.1055/s-2008-1035132.
3
Aids for eye drop administration.滴眼剂给药辅助工具。
Surv Ophthalmol. 2017 May-Jun;62(3):332-345. doi: 10.1016/j.survophthal.2016.12.009. Epub 2016 Dec 21.
4
Force requirements in topical medicine use--the squeezability factor.局部用药中的力需求——可挤压性因素。
Eye (Lond). 2011 Apr;25(4):466-9. doi: 10.1038/eye.2011.5. Epub 2011 Feb 4.
5
Role of opticare eye drop delivery system in patients with rheumatoid arthritis.Opticare眼药水给药系统在类风湿性关节炎患者中的作用。
J Rheumatol. 1999 Dec;26(12):2615-8.
6
A model for quantifying difficulty in squeezing eyedrops from their containers.
Arch Ophthalmol. 2007 Aug;125(8):1114-7. doi: 10.1001/archopht.125.8.1114.
7
An upright eyedrop bottle: accuracy, usage of excess drops, and contamination compared to a conventional bottle.直立式滴眼液瓶:与传统瓶相比的准确性、多余滴眼液的使用情况及污染情况
Clin Ophthalmol. 2016 Jul 28;10:1411-7. doi: 10.2147/OPTH.S104751. eCollection 2016.
8
Compliance aids--do they work?
Drugs Aging. 1992 Mar-Apr;2(2):103-11. doi: 10.2165/00002512-199202020-00004.
9
Evaluating eye drop instillation technique in glaucoma patients.评估青光眼患者滴眼剂滴入技术。
J Glaucoma. 2012 Mar;21(3):189-92. doi: 10.1097/IJG.0b013e31820bd2e1.
10
Comparison of eyedrop instillation technique with and without a delivery device in inexperienced patients.在无经验的患者中使用和不使用给药装置滴眼技术的比较。
Eur J Ophthalmol. 2016 Nov 4;26(6):594-597. doi: 10.5301/ejo.5000797. Epub 2016 Apr 27.

引用本文的文献

1
Dry eye disease treatment improves subjective quality-of-life responses in patients with AMD, independent of disease stage.干眼症治疗可改善年龄相关性黄斑变性患者的主观生活质量反应,与疾病阶段无关。
PLoS One. 2025 Feb 6;20(2):e0318733. doi: 10.1371/journal.pone.0318733. eCollection 2025.
2
In Vitro/Ex Vivo Release Study of a Ground Umbilical Cord Matrix Loaded with Dexamethasone.载有地塞米松的研磨脐带基质的体外/离体释放研究
J Funct Biomater. 2024 Jun 5;15(6):157. doi: 10.3390/jfb15060157.
3
Eyedrop Instillation Techniques, Difficulties, and Currently Available Solutions: A Literature Review.

本文引用的文献

1
Self-medication with pilocarpine among outpatients in a glaucoma clinic.青光眼门诊患者自行使用毛果芸香碱进行自我药疗。
Br J Ophthalmol. 1980 Feb;64(2):137-41. doi: 10.1136/bjo.64.2.137.
2
Patient administration of eyedrops: observation. Part II.患者滴眼剂用药:观察。第二部分。
Ann Ophthalmol. 1982 Sep;14(9):889-93.
3
Part I. Patient administration of eyedrops: interview.第一部分:眼药水的患者使用:访谈。
滴眼剂滴注技术、难点及当前可用解决方案:文献综述
J Curr Ophthalmol. 2024 Mar 29;35(3):226-230. doi: 10.4103/joco.joco_308_22. eCollection 2023 Jul-Sep.
4
Next generation therapeutics for retinal neurodegenerative diseases.视网膜神经退行性疾病的下一代治疗方法。
J Control Release. 2024 Mar;367:708-736. doi: 10.1016/j.jconrel.2024.01.063. Epub 2024 Feb 10.
5
Contact lens as an emerging platform for ophthalmic drug delivery: A systematic review.隐形眼镜作为眼科药物递送的新兴平台:一项系统评价。
Asian J Pharm Sci. 2023 Sep;18(5):100847. doi: 10.1016/j.ajps.2023.100847. Epub 2023 Sep 27.
6
Challenging the "Topical Medications-First" Approach to Glaucoma: A Treatment Paradigm in Evolution.挑战青光眼“局部用药优先”的治疗方法:一种不断演变的治疗模式。
Ophthalmol Ther. 2023 Dec;12(6):2823-2839. doi: 10.1007/s40123-023-00831-9. Epub 2023 Oct 19.
7
Adherence and Persistence to Medical Therapy in Glaucoma: An Overview.青光眼治疗的依从性和持续性:综述
Ophthalmol Ther. 2023 Oct;12(5):2227-2240. doi: 10.1007/s40123-023-00730-z. Epub 2023 Jun 14.
8
Intraoperative subconjunctival steroid reduces the incidence of pseudophakic macular oedema: a cohort study of 20,066 consecutive phacoemulsification surgeries.术中球结膜下注射类固醇可降低后发性白内障黄斑水肿的发生率:20066 例连续超声乳化白内障吸除术的队列研究。
Eye (Lond). 2023 Jul;37(10):2077-2081. doi: 10.1038/s41433-022-02290-1. Epub 2022 Oct 22.
9
Mucoadhesive Marine Polysaccharides.黏附性海洋多糖。
Mar Drugs. 2022 Aug 15;20(8):522. doi: 10.3390/md20080522.
10
Glaucoma Treatment and Hydrogel: Current Insights and State of the Art.青光眼治疗与水凝胶:当前见解与技术现状
Gels. 2022 Aug 17;8(8):510. doi: 10.3390/gels8080510.
Ann Ophthalmol. 1982 Aug;14(8):775-9.
4
Compliance with treatment of patients with chronic open-angle glaucoma.慢性开角型青光眼患者的治疗依从性。
Br J Ophthalmol. 1983 Jan;67(1):46-9. doi: 10.1136/bjo.67.1.46.
5
Facilitating patient compliance in glaucoma therapy.促进青光眼治疗中患者的依从性。
Surv Ophthalmol. 1983 Dec;28 Suppl:252-8. doi: 10.1016/0039-6257(83)90142-x.
6
Improper topical self-administration of ocular medication among patients with glaucoma.
Can J Ophthalmol. 1984 Feb;19(1):2-5.
7
Drop aid.
Trans Am Acad Ophthalmol Otolaryngol. 1967 Mar-Apr;71(2):368.
8
Methods for self-administration of eyedrops.眼药水自我给药方法。
Ann Ophthalmol. 1985 Dec;17(12):768-9.
9
Drop size of commercial glaucoma medications.
Am J Ophthalmol. 1986 Jun 15;101(6):691-4. doi: 10.1016/0002-9394(86)90771-3.
10
The compliance factor.顺应性因素。
Am J Ophthalmol. 1986 May 15;101(5):609-10. doi: 10.1016/0002-9394(86)90954-2.